AUTHOR=Chen Jin-Nan , Zhang Qing-Wei , Pan Yuan-Bo , Wang Qi-Wen , Zhang Xin-Tian , Li Xiao-Bo 

TITLE=Young-Onset Early Colorectal Cancer Had Similar Relative Survival to but Better Overall Survival Than Conventional Early Colorectal Cancer: A Large Population-Based Study

JOURNAL=Frontiers in Oncology

VOLUME=10

YEAR=2020

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00096

DOI=10.3389/fonc.2020.00096

ISSN=2234-943X

ABSTRACT=<p><bold>Background:</bold> There existed limited evidence about prognosis of young-onset early colorectal cancer (ECRC). In the present study, we aimed to compare prognosis between patients with young-onset ECRCs and patients with conventional ECRCs.</p><p><bold>Method:</bold> Patients with surgically resected, histologically diagnosed ECRCs were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database. Young-onset ECRC was defined as ECRC occurring in patients aged &lt;50 years. Five-years relative survival was calculated at the time of diagnosed year and linear regression was performed to analyze the association between 5-years relative survival and age. The multivariate Cox regression, multivariate competing risk model, and propensity score matching (PSM) and univariate analysis weighted by the inverse probability of treatment weight (IPTW) were used to compare overall survival (OS) between young-onset ECRCs and conventional ECRCs.</p><p><bold>Results:</bold> A total of 51,197 ECRCs were retrieved from SEER database, including 4,634 young-onset ECRCs and 46,563 conventional ECRCs. Five-years relative survival was found to be moderately associated with different age groups (<italic>R</italic> = −0.725, <italic>P</italic> = 0.0034). Patients with young-onset ECRCs (96.7%) had similar 5-years relative survival compared with conventional ECRCs (96.3%). However, multivariate Cox regression [HR (hazard ratio), 0.18; 95% CI: 0.16–0.20; <italic>P</italic> &lt; 0.001] showed better OS in young-onset ECRCs. After PSM, we still found favored prognosis for young-onset ECRCs under univariate Cox regression (HR, 0.18; 95% CI: 0.16–0.21; <italic>P</italic> &lt; 0.001). Similar results could also be found in the univariate Cox regression weighted by IPTW (HR, 0.17; 95% CI: 0.17–0.18; <italic>P</italic> &lt; 0.001).</p><p><bold>Conclusions:</bold> Patients with young-onset ECRCs had similar relative survival but better OS compared with conventional ECRCs.</p>